What we're reading, December 9, 2015: the federal government recovered $200 million from state's whose health insurance exchanges faltered; drug cocktails are responsible for majority of drug overdose deaths in Massachusetts; and healthcare organizations are not confident in their ability to share patient data while protecting patient privacy.
The Affordable Care Act remains a controversial topic in the United States, but the government recently announced it has been able to recoup more than $200 million in funding from states that tried to set up their own health insurance exchanges and ran into problems. The federal government had granted more than $4 billion to 17 states, but exchanges have struggled and Hawaii, Nevada, and Oregon all chose to close their exchanges, reported The Wall Street Journal.
The majority of drug overdose deaths in Massachusetts are being attributed to drug cocktails that combine a prescription opioid or heroin with some other drug or alcohol. Kaiser Health News reported that an analysis from the Harvard T.H. Chan School of Public Health found fentanyl, which is more powerful than heroin, was present in more than one-third of the deaths. Even physicians specializing in addiction medicine and who treat patients in recovery face the challenge of what to prescribe that won’t cause a serious adverse reaction.
Demand for access to health data is on the rise, but healthcare organizations might not be able to ensure patient privacy, according to a new survey. More than two-thirds of healthcare organizations lack complete confidence in their ability to share data without risking patients’ privacy, according to Healthcare Informatics. In addition, the survey found individuals lack familiarity with advanced methods of de-identifying data and most organizations use data sharing approaches that increase risk.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More